Brief: Promore Pharma Gets Patent Regarding Skin Scarring In U.S.

PMD Device Solutions AB

12/05/2021 13:25

May 12 (Reuters) - Promore Pharma AB  PROMO.ST :
    * PROMORE PHARMA IS GRANTED A US PATENT REGARDING SKIN SCARRING
    * COMPANY ESTIMATES THAT ANNUAL ADDRESSABLE MARKET EXCEEDS SEK 100 BLN
    * PATENT PERIOD EXTENDS AT LEAST UNTIL 2030, WITH POSSIBILITIES OF FURTHER PATENT EXTENSION.

Source text for Eikon:  ID:nMFNx9wmq 
Further company coverage:  PROMO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))